Co-Authors
This is a "connection" page, showing publications co-authored by David Herrington and Nicklaus Ashburn.
Connection Strength
0.724
-
Ashburn NP, Snavely AC, Ehrig MR, Shapiro MD, Herrington DM, Reboussin DM, Gesell SB, Mahler SA. Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial. Crit Pathw Cardiol. 2025 Sep 01; 24(3):e0390.
Score: 0.230
-
Ashburn NP, Snavely AC, Ehrig MR, Shapiro MD, Herrington DM, Reboussin DM, Gesell SB, Mahler SA. Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) Trial. Crit Pathw Cardiol. 2025 Apr 22.
Score: 0.230
-
Ashburn NP, Snavely AC, Allen BR, Christenson RH, Herrington DM, Hiestand BC, Miller CD, Stopyra JP, Mahler SA. Monocyte chemoattractant protein-1 is not predictive of cardiac events in patients with non-low-risk chest pain. Emerg Med J. 2021 Dec 21.
Score: 0.182
-
Smith LM, Ashburn NP, Snavely AC, Stopyra JP, Lenoir KM, Wells BJ, Hiestand BC, Herrington DM, Miller CD, Mahler SA. Identification of very low-risk acute chest pain patients without troponin testing. Emerg Med J. 2020 Nov; 37(11):690-695.
Score: 0.041
-
Stopyra J, Snavely AC, Hiestand B, Wells BJ, Lenoir KM, Herrington D, Hendley N, Ashburn NP, Miller CD, Mahler SA. Comparison of accelerated diagnostic pathways for acute chest pain risk stratification. Heart. 2020 Jul; 106(13):977-984.
Score: 0.041